RH Bophelo Ltd (RHB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, RH Bophelo Ltd (RHB) has a cash flow conversion efficiency ratio of -0.003x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ZAC-3.81 Million ≈ $-2.02K USD) by net assets (ZAC1.10 Billion ≈ $582.91K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See RHB days of operational coverage to measure how many days the company can operate on defensive assets alone.
RH Bophelo Ltd - Cash Flow Conversion Efficiency Trend (2017–2026)
This chart illustrates how RH Bophelo Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
RH Bophelo Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RH Bophelo Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Metal Hawk Ltd
AU:MHK
|
-0.079x |
|
AIxCrypto Holdings, Inc.
NASDAQ:AIXC
|
-0.056x |
|
Absolicon Solar Collector AB Series B
ST:ABSL-B
|
-0.041x |
|
Brikor Ltd
JSE:BIK
|
0.055x |
|
LabGenomics Co. Ltd
KQ:084650
|
-0.034x |
|
Vectus Biosystems Ltd
AU:VBS
|
2.572x |
|
CASA DE BUCOVINA-CLUB DE MUNTE
RO:BCM
|
-0.009x |
|
Exact Therapeutics AS
OL:EXTX
|
-0.697x |
Annual Cash Flow Conversion Efficiency for RH Bophelo Ltd (2017–2026)
The table below shows the annual cash flow conversion efficiency of RH Bophelo Ltd from 2017 to 2026. For the full company profile with market capitalisation and key ratios, see RHB stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-02-28 | ZAC1.10 Billion ≈ $582.91K |
ZAC-16.50 Million ≈ $-8.77K |
-0.015x | -793.71% |
| 2025-02-28 | ZAC1.08 Billion ≈ $573.04K |
ZAC2.34 Million ≈ $1.24K |
0.002x | +106.63% |
| 2024-02-29 | ZAC1.03 Billion ≈ $549.69K |
ZAC-33.83 Million ≈ $-17.98K |
-0.033x | -377.30% |
| 2023-02-28 | ZAC871.74 Million ≈ $463.29K |
ZAC10.28 Million ≈ $5.46K |
0.012x | +183.44% |
| 2022-02-28 | ZAC903.96 Million ≈ $480.41K |
ZAC3.76 Million ≈ $2.00K |
0.004x | +130.64% |
| 2021-02-28 | ZAC864.08 Million ≈ $459.21K |
ZAC-11.74 Million ≈ $-6.24K |
-0.014x | -290.78% |
| 2020-02-29 | ZAC646.61 Million ≈ $343.64K |
ZAC4.60 Million ≈ $2.45K |
0.007x | -26.15% |
| 2019-02-28 | ZAC530.12 Million ≈ $281.73K |
ZAC5.11 Million ≈ $2.72K |
0.010x | -57.91% |
| 2018-02-28 | ZAC495.66 Million ≈ $263.42K |
ZAC11.35 Million ≈ $6.03K |
0.023x | -- |
| 2017-02-28 | ZAC1.00 ≈ $0.00 |
ZAC0.00 ≈ $0.00 |
0.000x | -- |
About RH Bophelo Ltd
RH Bophelo Limited, together with its subsdidiaries, invests in the healthcare and financial sector in South Africa. It is involved in investment of equity, quasi-equity, and equity related investments in healthcare and financial services, primarily in operational infrastructure, health insurance, private hospital infrastructure, pharmaceuticals, retail and distribution, and healthcare technology… Read more